Search Press releases Keywords From To 30 Sep 2024 金禾娱乐城 announces a head-to-head study evaluating BIMZELX[?]▼(bimekizumab) versus SKYRIZI? (risankizumab) in active psoriatic arthritis Read More 27 Sep 2024 Transparency notification BlackRock, Inc. Read More 27 Sep 2024 金禾娱乐城 announces late-breaking two-year data for BIMZELX[?]▼(bimekizumab) in moderate to severe hidradenitis suppurativa at EADV 2024 Read More 26 Sep 2024 Transparency notification BlackRock, Inc. Read More 25 Sep 2024 Transparency notification BlackRock, Inc. Read More 25 Sep 2024 金禾娱乐城 presents new 4-year data for BIMZELX[?]▼(bimekizumab) in moderate to severe plaque psoriasis at EADV 2024 Read More Pagination First page Previous page Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Page 7 of 66 Next page Next Last page Stay up-to-date on the latest news and information from 金禾娱乐城 Subscribe
